The Zfp868 Inhibitors chemical class is an intriguing group of compounds that indirectly target the activity of the Zfp868 protein. This class primarily includes histone deacetylase (HDAC) inhibitors and DNA methyltransferase inhibitors, reflecting the importance of epigenetic modifications in the regulation of gene expression relevant to Zfp868.
HDAC inhibitors like Trichostatin A, Vorinostat, Valproic Acid, Entinostat, Panobinostat, Romidepsin, Belinostat, Quisinostat, and Givinostat play a pivotal role in this class. These inhibitors modulate the acetylation state of histones, leading to changes in chromatin structure and accessibility. This alteration in the epigenetic landscape can influence the expression of a wide array of genes, including those directly or indirectly associated with Zfp868. By relaxing the chromatin structure, these compounds allow for increased transcriptional activity of genes that could regulate or be regulated by Zfp868. The broad-spectrum nature of some of these inhibitors, like Panobinostat, allows for a wide-ranging impact on gene expression, which is crucial for investigating the complex regulatory networks in which Zfp868 operates.
On the other hand, the inclusion of DNA methyltransferase inhibitors such as 5-Azacytidine and Decitabine in this class highlights the role of DNA methylation in gene expression control. By inhibiting DNA methylation, these compounds can lead to the reactivation of silenced genes, which could include regulators or effectors of Zfp868. The altered methylation pattern can have significant repercussions on gene expression profiles, thereby indirectly affecting the function and regulation of Zfp868.
Additionally, Anacardic Acid, a histone acetyltransferase inhibitor, represents another aspect of epigenetic control. By inhibiting histone acetylation, it provides a counterbalance to the actions of HDAC inhibitors, offering a nuanced approach to modulating gene expression associated with Zfp868.
Overall, the Zfp868 Inhibitors class is characterized by its focus on epigenetic mechanisms. This focus underscores the emerging understanding of how chromatin remodeling and DNA methylation are integral to the regulation of complex gene networks. The diverse range of compounds within this class provides researchers with a versatile toolkit to explore the intricate molecular pathways associated with Zfp868, offering insights into its role and regulation within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor, could influence gene expression mechanisms that indirectly modulate Zfp868. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, potentially alters DNA methylation patterns affecting Zfp868 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC inhibitor, may change chromatin structure and affect Zfp868 activity through epigenetic modifications. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Inhibits histone acetyltransferase, potentially affecting gene expression related to Zfp868. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Another DNA methyltransferase inhibitor, could influence Zfp868 by altering gene methylation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
HDAC inhibitor, may modulate gene expression profiles impacting Zfp868 function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Specific HDAC inhibitor, potentially alters histone acetylation and gene expression affecting Zfp868. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Broad-spectrum HDAC inhibitor, could affect a wide range of genes including those related to Zfp868 activity. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
HDAC inhibitor, may influence chromatin remodeling and subsequent gene expression relevant to Zfp868. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
HDAC inhibitor, could change the expression of genes involved in the signaling pathways of Zfp868. | ||||||